Pulmonx Corporation

6.52
-0.30 (-4.40%)
At close: Mar 31, 2025, 12:34 PM

Pulmonx Statistics

Share Statistics

Pulmonx has 39.8M shares outstanding. The number of shares has increased by 2.47% in one year.

Shares Outstanding 39.8M
Shares Change (YoY) 2.47%
Shares Change (QoQ) 0.86%
Owned by Institutions (%) 91.33%
Shares Floating 34.23M
Failed to Deliver (FTD) Shares 27
FTD / Avg. Volume 0.01%

Short Selling Information

The latest short interest is 1.25M, so 3.18% of the outstanding shares have been sold short.

Short Interest 1.25M
Short % of Shares Out 3.18%
Short % of Float 3.5%
Short Ratio (days to cover) 5.29

Valuation Ratios

The PE ratio is -4.71 and the forward PE ratio is -3.83. Pulmonx's PEG ratio is 0.47.

PE Ratio -4.71
Forward PE -3.83
PS Ratio 3.17
Forward PS 0.8
PB Ratio 3.09
P/FCF Ratio -8.05
PEG Ratio 0.47
Financial Ratio History

Enterprise Valuation

Pulmonx Corporation has an Enterprise Value (EV) of 441.82M.

EV / Earnings -7.83
EV / Sales 5.27
EV / EBITDA -7.66
EV / EBIT -7.66
EV / FCF -13.39

Financial Position

The company has a current ratio of 5.58, with a Debt / Equity ratio of 0.66.

Current Ratio 5.58
Quick Ratio 4.88
Debt / Equity 0.66
Total Debt / Capitalization 39.69
Cash Flow / Debt -0.56
Interest Coverage -16.45

Financial Efficiency

Return on equity (ROE) is -0.66% and return on capital (ROIC) is -40.92%.

Return on Equity (ROE) -0.66%
Return on Assets (ROA) -0.35%
Return on Capital (ROIC) -40.92%
Revenue Per Employee $287,934.71
Profits Per Employee $-193,793.81
Employee Count 291
Asset Turnover 0.51
Inventory Turnover 1.29

Taxes

Income Tax 500K
Effective Tax Rate -0.01

Stock Price Statistics

The stock price has increased by -26.43% in the last 52 weeks. The beta is 0.51, so Pulmonx's price volatility has been higher than the market average.

Beta 0.51
52-Week Price Change -26.43%
50-Day Moving Average 7.16
200-Day Moving Average 6.91
Relative Strength Index (RSI) 40.97
Average Volume (20 Days) 314.15K

Income Statement

In the last 12 months, Pulmonx had revenue of 83.79M and earned -56.39M in profits. Earnings per share was -1.44.

Revenue 83.79M
Gross Profit 62M
Operating Income -57.7M
Net Income -56.39M
EBITDA -57.7M
EBIT -57.7M
Earnings Per Share (EPS) -1.44
Full Income Statement

Balance Sheet

The company has 70.91M in cash and 56.47M in debt, giving a net cash position of 14.43M.

Cash & Cash Equivalents 70.91M
Total Debt 56.47M
Net Cash 14.43M
Retained Earnings -467.56M
Total Assets 162.85M
Working Capital 111.81M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -31.54M and capital expenditures -1.45M, giving a free cash flow of -32.98M.

Operating Cash Flow -31.54M
Capital Expenditures -1.45M
Free Cash Flow -32.98M
FCF Per Share -0.84
Full Cash Flow Statement

Margins

Gross margin is 74%, with operating and profit margins of -68.87% and -67.3%.

Gross Margin 74%
Operating Margin -68.87%
Pretax Margin -66.71%
Profit Margin -67.3%
EBITDA Margin -68.87%
EBIT Margin -68.87%
FCF Margin -39.37%

Dividends & Yields

LUNG does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -21.11%
FCF Yield -12.16%
Dividend Details

Analyst Forecast

The average price target for LUNG is $12, which is 76% higher than the current price. The consensus rating is "Buy".

Price Target $12
Price Target Difference 76%
Analyst Consensus Buy
Analyst Count 7
Stock Forecasts

Scores

Altman Z-Score -1.8
Piotroski F-Score 4